Yotsukura J, Huang H, Singh A K, Shichi H
Department of Ophthalmology, Wayne State University, School of Medicine, Detroit, Michigan 48201, USA.
Cell Immunol. 1997 Dec 15;182(2):89-98. doi: 10.1006/cimm.1997.1229.
Intratesticular injection of a retinal protein (S-antigen) into Lewis rats induces systemic immunotolerance (designated orchidic tolerance) and renders animals refractory to experimental autoimmune uveoretinitis (EAU) produced by S-antigen immunization. We demonstrated in this work that the immunotolerance could be transferred to syngeneic naive rats by both CD4+ and CD8+ regulatory cells. Attempts were then made to characterize the cytokines involved in the immunosuppressive activity of these regulatory cells. Using the in vitro lymphoproliferation assay, the inhibitory effect of CD4+ cells on effector cells was found to be reversed by antibodies against IL-4 and IL-10 but not by anti-TGF-beta antibody. IL-4 (IC50 = 1.6 ng/10(6) cells) and IL-10 (IC50 = 0.6 ng/10(6) cells) added to the assay medium were potent inhibitors of effector cell proliferation. Increased immunoreactivity and mRNA expression for IL-4 and IL-10 was observed for CD4+ regulatory cells. The inhibitory effect of CD8+ regulatory cells was reversed by anti-TGF-beta antibody but not by antibodies against IL-4 and IL-10. Compared with control CD8+ cells, CD8+ cells from tolerized rats demonstrated higher immunoreactivity for TGF-beta but did not show an enhanced expression of mRNA for TGF-beta. TGF-beta 1 and TGF-beta 2 added to effector cells showed dichotomous effects; both isoforms stimulated cell proliferation at 2.5 ng/10(6) cells and inhibited at lower or higher concentrations. These results led us to conclude that IL-4 and IL-10 are important cytokines for the immunosuppressive effect of CD4+ regulatory cells generated in orchidic tolerance. TGF-beta is an important immunosuppressive cytokine for CD8+ regulatory cells but further studies will determine whether other cytokines are also involved.
将视网膜蛋白(S抗原)睾丸内注射到Lewis大鼠体内可诱导全身免疫耐受(称为睾丸耐受),使动物对S抗原免疫诱导的实验性自身免疫性葡萄膜视网膜炎(EAU)产生抵抗。我们在这项研究中证明,免疫耐受可通过CD4+和CD8+调节细胞转移至同基因的未致敏大鼠。随后我们试图鉴定参与这些调节细胞免疫抑制活性的细胞因子。使用体外淋巴细胞增殖试验,发现抗IL-4和抗IL-10抗体可逆转CD4+细胞对效应细胞的抑制作用,而抗TGF-β抗体则不能。添加到试验培养基中的IL-4(IC50 = 1.6 ng/10(6) 细胞)和IL-10(IC50 = 0.6 ng/10(6) 细胞)是效应细胞增殖的有效抑制剂。观察到CD4+调节细胞中IL-4和IL-10的免疫反应性和mRNA表达增加。抗TGF-β抗体可逆转CD8+调节细胞的抑制作用,而抗IL-4和抗IL-10抗体则不能。与对照CD8+细胞相比,来自耐受大鼠的CD8+细胞对TGF-β表现出更高的免疫反应性,但未显示TGF-β mRNA表达增强。添加到效应细胞中的TGF-β1和TGF-β2表现出不同的作用;两种异构体在2.5 ng/10(6) 细胞时刺激细胞增殖,在较低或较高浓度时则抑制细胞增殖。这些结果使我们得出结论,IL-4和IL-10是睾丸耐受中产生的CD4+调节细胞免疫抑制作用的重要细胞因子。TGF-β是CD8+调节细胞的重要免疫抑制细胞因子,但进一步的研究将确定是否还有其他细胞因子也参与其中。